disease-specific [9] and evolves over time. [10] The analysis of corona composition comparing healthy subjects and patients led to accurate diagnostic results in pancreatic cancer [11][12][13] and glioblastoma research. [14] From a methodological point of view, BC isolation and extraction are generally obtained by incubating NPs at a controlled temperature and then purifying samples by washing losingly attached proteins via different methods [15] before proteomics analysis. However, BC composition can be affected by methodologies used for sample preparation, storage, and analysis, leading to possible misinterpretations. In an effort of standardization, a series of recommendations have been recently postulated for BC scientists, to improve the accuracy and robustness of BC results. In 2019, the checklist for experimental design and reporting guidelines to outline Minimum Information about Nanomaterial Biocorona Experiments (MINBE) has been proposed. [16] MINBE consists of four main questions concerning exposure to biofluids, isolation, separation, and analysis and aims at correctly reporting experimental conditions to compare different study results. Furthermore, in a recent paper, it has been highlighted how analysis of BC should foresee proper characterization of nanoparticle polydispersity, rigorous authentication of biological fluids, accurate control samples, and contamination control. [17] Despite this, there are still open questions concerning the appropriate methodology for BC sample preparation. First, it is not clear how operator bias is relevant to results obtained in different laboratories and/ or in comparison with automated analysis systems. Second, protocol step criticalities consist of i) the number of washes before BC analysis, ii) the order of incubation steps, and iii) the concentration of the biological fluid. This work focuses on the assessment of the influence of these parameters on BC results. To this aim, three NP types, i.e., gold NPs, graphene oxide (GO) nanoflakes, and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) cationic liposomes (CLs) have been incubated with HP to determine the effect of protocol steps in BC results. Initially, we compared results obtained from the same samples processed by operators working in different laboratories and verified whether operator variability could be affected by using automatic tools. Then, the protocol has been varied by using different plasma concentrations, diluting samples in various stages, and changing the number of washing steps before BC analysis. We conclude this work by appealing to researchers to